Nintedanib for progressive fibrosing interstitial lung disease: how many meet criteria in a UK district general hospital systemic sclerosis cohort?
Affiliation
The Dudley Group NHS Foundation TrustPublication date
03/04/2023Subject
Rheumatology
Metadata
Show full item recordCitation
Ho GN, Douglas KMJ. Nintedanib for progressive fibrosing interstitial lung disease: how many meet criteria in a UK district general hospital systemic sclerosis cohort? Rheumatol Adv Pract. 2023 Apr 3;7(2):rkad037. doi: 10.1093/rap/rkad037. PMID: 37065010; PMCID: PMC10097451.Type
ArticlePMID
37065010Publisher
Oxford University Pressae974a485f413a2113503eed53cd6c53
10.1093/rap/rkad037